FDA Logo links to FDA home page
HHS Logo links to Department of Health and Human Services website
U.S. Food and Drug Administration

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On June 25, 2004
Table of Contents
Docket # Title
1998N-0359 Program priorities/Center for Food Safety & Applied Nutritin
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2003N-0456 Agency Information Collection:Prevention of Medical Gas Mix-ups at Health Care Facilities
2003N-0468 Medical Devices; Effective Date of Requirement for Premarket
2004M-0012 P030002, crystalens Model AT-45 Accommodating Posterior Chamber Intraocular Lens (IOL),
2004M-0022 P010059 - Morcher Capsular Tension Ring, Types 14, 14A and 14C, Approved 10/23/03
2004M-0024 P970020/S040 - ACS MULTI-LINK RX DUET, ACS MULTI-LINK OTW DUET, ACS MULTI-LINK RX TRISTAR, ACS MULTI-LINK OTW TRISTAR, ACS MULTI-LINK RX ULTRA, ACS MULTI-LINK OTW ULTRA, ACS MULTI-LINK RX TETRA, ACS M
2004M-0031 PMA P020031, Microsulis Microwave Endometrial Ablation (MEA) System
2004M-0064 P030005 - CONTAK RENEWAL TR Models H125 and H120 with the Model 2865 Version 1.8 Application Software
2004M-0084 HDE Number: H030004; Applicant: Menssana Research Inc.; Device Tradename: Heartsbreath
2004M-0090 H030003, DeBakey VAD Child Left Ventricular Assist System
2004M-0116 P030006 - Prolieve Thermodilatation System
2004M-0134 Refractec, Inc.; PMA Approval of ViewPoint TM CK R System, P010018/S005
2004M-0145 P020006 - Enteryx Procedure Kit, Approved 4/22/03
2004M-0147 P890064/S009 - Digene Hybrid Capture 2 (HC2) High-Risk HPV DNA Test
2004N-0194 DEFINITION OF PRIMARY MODE OF ACTION OF A COMBINATION PRODUCT
2004N-0226 Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
2004P-0271 Determine that Drying Lotion, a Topical Acne Drug Products for Over the Counter Human Use in 21 CFR 333 Subpart D can contain in combination both Sulfur (10.0%) and Salicylic Acid (2.0%) as the active
2004Q-0151 Qualified Health Claim (QHC): soy protein and cancer
1998N-0359 Program priorities/Center for Food Safety & Applied Nutritin
N 6 FDA Vol #: 8
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 7300 L. Dator Vol #: 279
EMC 7301 no name Vol #: 279
EMC 7302 no name Vol #: 279
EMC 7303 E. Smith Vol #: 279
EMC 7304 R. S. Tannenbaum Vol #: 279
EMC 7305 K. McKenna Vol #: 279
EMC 7306 F. M. Thalacker Vol #: 279
EMC 7307 M. McMartin Vol #: 279
EMC 7308 M. Sheehan Vol #: 279
EMC 7309 Lisa Parsley, RN MSN Vol #: 279
EMC 7310 S. Landers Vol #: 279
EMC 7311 D. Jackson Vol #: 279
EMC 7312 L. Huddleston Vol #: 279
EMC 7313 M. Bagnal Vol #: 279
EMC 7314 N. Petrow Vol #: 279
EMC 7315 J. Tierney Vol #: 279
EMC 7316 Blanca Vol #: 279
EMC 7317 I. Nossel Vol #: 279
EMC 7318 I. Nossel Vol #: 279
EMC 7319 V. Kallianes Vol #: 279
EMC 7320 E. Rodacker Vol #: 279
EMC 7321 D. Gary Vol #: 279
EMC 7322 M. Przygoda Vol #: 279
EMC 7323 R. Johnson Vol #: 279
EMC 7324 N. Puffett Vol #: 279
EMC 7325 K. McVicker Vol #: 279
EMC 7326 K. Kesler Vol #: 279
EMC 7327 C. Gallopin Vol #: 279
EMC 7328 A. Riley Vol #: 279
EMC 7329 S. White Vol #: 279
EMC 7330 R. Clary Vol #: 279
EMC 7331 L. Howe Vol #: 279
EMC 7332 S. Smith Vol #: 279
EMC 7333 C. Siverson Vol #: 279
EMC 7334 K. Weigle Vol #: 279
EMC 7335 L. Christiansen Vol #: 279
EMC 7336 A. Meza Vol #: 279
EMC 7337 J. A. Bylander Vol #: 279
EMC 7338 R. Wayne Vol #: 279
EMC 7339 J. M. Mack, P.E. Vol #: 279
EMC 7340 L. Frankel Vol #: 279
EMC 7341 K. Wujcik Vol #: 279
EMC 7342 M. Boyle Vol #: 279
EMC 7343 R. Olson Vol #: 279
EMC 7344 P. D. Simmons PH.D. Vol #: 279
EMC 7345 J. Miles Vol #: 279
EMC 7346 S. Kugelmass Vol #: 279
EMC 7347 H. Yee Vol #: 279
EMC 7348 C. M. Barber Vol #: 279
EMC 7349 S. Siegfriedt Vol #: 279
EMC 7350 L. McPherson Vol #: 279
EMC 7351 L. Schurmann Vol #: 279
EMC 7352 M. Matzkin Vol #: 279
EMC 7353 Rev. G. McFarland Vol #: 279
EMC 7354 K. Franklin Vol #: 279
EMC 7355 E. G. Reardon Vol #: 279
EMC 7356 E. Koskan Vol #: 279
EMC 7357 K. Troyan Vol #: 279
EMC 7358 S. Rose Vol #: 279
EMC 7359 K. Koch Vol #: 279
EMC 7360 M. Monroe Vol #: 279
EMC 7361 S. Goodall Vol #: 279
EMC 7362 S. Goodall Vol #: 279
EMC 7363 C. Mcneilly Vol #: 279
EMC 7364 K. Attfield Vol #: 279
EMC 7365 P. Mackey Vol #: 279
EMC 7366 Amelia Blakeman Vol #: 279
EMC 7367 J. Strathy Vol #: 279
EMC 7368 J. Reise Vol #: 279
EMC 7369 T. Hester Vol #: 279
EMC 7370 J. Warren-findlow Vol #: 279
EMC 7371 C. Christiansen Vol #: 279
EMC 7372 K. Smith Vol #: 279
EMC 7373 J. Bowie Vol #: 279
EMC 7374 Z. Brown Vol #: 279
EMC 7375 J. Gaddis Vol #: 279
EMC 7376 M. Crissman Vol #: 279
EMC 7377 P. Hornsey Vol #: 279
EMC 7378 T. Norelli Vol #: 279
EMC 7379 N. Pechenik Vol #: 279
EMC 7380 D. Evans Vol #: 279
EMC 7381 E. Armm Vol #: 279
EMC 7382 J. Reynolds Vol #: 279
EMC 7383 L. Reinhart Vol #: 279
EMC 7384 P. J. Shulman Vol #: 279
EMC 7385 J. Krinsky-Rubber Vol #: 279
EMC 7386 J. Forlani Vol #: 279
EMC 7387 T. Swan Vol #: 279
EMC 7388 K. Miller Vol #: 279
EMC 7389 N. Myhre Vol #: 279
EMC 7390 M. Jackson Vol #: 279
EMC 7391 M. Prosser Vol #: 279
EMC 7392 P. Futerer Vol #: 279
EMC 7393 M. Pohlman Vol #: 279
EMC 7394 K. Wamsley Vol #: 279
EMC 7395 L. Smith Vol #: 279
EMC 7396 J. Moless Vol #: 279
EMC 7397 M. Salt Vol #: 279
EMC 7398 J. Fox Vol #: 279
EMC 7399 M. Fleming Vol #: 279
EMC 7400 L. D. Berkowitz Vol #: 279
EMC 7401 L. Goldfine Vol #: 279
EMC 7402 A. E. Johnsrud Vol #: 279
2003N-0456 Agency Information Collection:Prevention of Medical Gas Mix-ups at Health Care Facilities
N 3 FDA Vol #: 1
2003N-0468 Medical Devices; Effective Date of Requirement for Premarket
NFR 1 FDA Vol #: 1
2004M-0012 P030002, crystalens Model AT-45 Accommodating Posterior Chamber Intraocular Lens (IOL),
N 1 FDA Vol #: 1
2004M-0022 P010059 - Morcher Capsular Tension Ring, Types 14, 14A and 14C, Approved 10/23/03
N 1 FDA Vol #: 1
2004M-0024 P970020/S040 - ACS MULTI-LINK RX DUET, ACS MULTI-LINK OTW DUET, ACS MULTI-LINK RX TRISTAR, ACS MULTI-LINK OTW TRISTAR, ACS MULTI-LINK RX ULTRA, ACS MULTI-LINK OTW ULTRA, ACS MULTI-LINK RX TETRA, ACS M
N 1 FDA Vol #: 1
2004M-0031 PMA P020031, Microsulis Microwave Endometrial Ablation (MEA) System
N 1 FDA Vol #: 1
2004M-0064 P030005 - CONTAK RENEWAL TR Models H125 and H120 with the Model 2865 Version 1.8 Application Software
N 1 FDA Vol #: 1
2004M-0084 HDE Number: H030004; Applicant: Menssana Research Inc.; Device Tradename: Heartsbreath
N 1 FDA Vol #: 1
2004M-0090 H030003, DeBakey VAD Child Left Ventricular Assist System
N 1 FDA Vol #: 1
2004M-0116 P030006 - Prolieve Thermodilatation System
N 1 FDA Vol #: 1
2004M-0134 Refractec, Inc.; PMA Approval of ViewPoint TM CK R System, P010018/S005
N 1 FDA Vol #: 1
2004M-0145 P020006 - Enteryx Procedure Kit, Approved 4/22/03
N 1 FDA Vol #: 1
2004M-0147 P890064/S009 - Digene Hybrid Capture 2 (HC2) High-Risk HPV DNA Test
N 1 FDA Vol #: 1
2004N-0194 DEFINITION OF PRIMARY MODE OF ACTION OF A COMBINATION PRODUCT
NEC 1 FDA Vol #: 1
2004N-0226 Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
N 1 FDA Vol #: 1
2004P-0271 Determine that Drying Lotion, a Topical Acne Drug Products for Over the Counter Human Use in 21 CFR 333 Subpart D can contain in combination both Sulfur (10.0%) and Salicylic Acid (2.0%) as the active
CP 1
Tab 1, 2, 3, 4
D'ARCY Revolutionary Skincare Vol #: 1
2004Q-0151 Qualified Health Claim (QHC): soy protein and cancer
C 1 Vance's Manufacturing Inc Vol #: 4
EMC 3
Mr & Mrs Gerald and Deanna Hernesmaa Vol #: 4
EMC 4 Mr & Mrs Gerald and Deanna Hernesmaa Vol #: 4
EMC 5 Fundacion LACMAT IBFAN Argentina Vol #: 4
EMC 6 Relive International Inc Vol #: 5
EMC 7 American Soybean Association Vol #: 5
EMC 8 The Solae Company Vol #: 5
EMC 9 Weston A Price Foundation Vol #: 5
EMC 10 United Soybean Board Vol #: 5

Page created on June 28, 2004 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management